Article
Trachelogenin, a novel inhibitor of hepatitis C virus entry through CD81.
The Journal of general virology - 1 May 2016
Qian Xi-Jing, Jin Yong-Sheng, Chen Hai-Sheng, Xu Qing-Qiang, Ren Hao, Zhu Shi-Ying, Tang Hai-Lin, Wang Yan, Zhao Ping, Qi Zhong-Tian, Zhu Yong-Zhe
Abstract excerpt
Although much progress has been made in antiviral agents against hepatitis C virus (HCV) in recent years, novel HCV inhibitors with improved efficacy, optimized treatment duration and more affordable prices are still urgently needed. Here, we report the identification of a natural plant-derived lignan, trachelogenin (TGN), as a potent entry inhibitor of HCV without genotype specificity, and with low cytotoxicity....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
